A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application

PURPOSE: To assess and describe patient-reported outcomes (PROs) in women with locally advanced/unresectable or metastatic breast cancer (aBC/mBC) with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR + /HER2 −) status receiving palbociclib combination therapy in a US...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, David, Zhan, Lin, Mahtani, Reshma, McRoy, Lynn, Mitra, Debanjali, Reynolds, Maria, Odom, Dawn, Hollis, Kelly, Kaye, James A., Jones, Cheryl, Hargis, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062359/
https://www.ncbi.nlm.nih.gov/pubmed/33428072
http://dx.doi.org/10.1007/s10549-020-06082-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062359/
https://www.ncbi.nlm.nih.gov/pubmed/33428072
http://dx.doi.org/10.1007/s10549-020-06082-7

Ejemplares similares